University of Texas MD Anderson Cancer Center announces $2.5 billion 'Only Possible Here, Campaign to End Cancer' at event in ...

MD Anderson Cancer Center has publicly launched its largest fundraising effort ever — which has already received major ...

The University of Texas MD Anderson Cancer Center today launches its historic $2.5 billion comprehensive philanthropic campaign, Only Possible Here, The Campaign to End Cancer.

The University of Texas MD Anderson Cancer Center is one of the original 3 cancer treatment centers established after the 1971 National Cancer Act. It is a degree awarding institution and is connected ...

Cogent Biosciences' stock has soared after its lead asset, bezuclastinib plus sunitinib, outperformed sunitinib alone in a ...

PDS Biotechnology Corp (PDSB) reports promising trial results and strategic collaborations, despite financial hurdles and trial amendments.

Cogent Biosciences, Inc. stock soars after bezuclastinib's strong Phase 3 results in GIST. Click for my updated look at COGT ...

Revenue Guidance -- Management reiterated full-year fiscal 2025 revenue guidance of $26 million to $30 million and set Q4 ...

Investing.com -- Cogent Biosciences (NASDAQ:COGT) stock surged 120% after the company reported positive results from its Phase 3 PEAK trial testing bezuclastinib plus sunitinib in gastrointestinal ...

Q3 2025 Earnings Call Transcript November 13, 2025 Bionano Genomics, Inc. beats earnings expectations. Reported EPS is ...